Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.

[1]  Anthony E. Boitano,et al.  Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells , 2010, Science.

[2]  J. Dick,et al.  Comparison of human cord blood engraftment between immunocompromised mouse strains. , 2010, Blood.

[3]  H. Kiem,et al.  Large animal models of hematopoietic stem cell gene therapy , 2010, Gene Therapy.

[4]  L. Zon,et al.  Resolving the controversy about N-cadherin and hematopoietic stem cells. , 2010, Cell stem cell.

[5]  Ian A. White,et al.  Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. , 2010, Cell stem cell.

[6]  Colleen Delaney,et al.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution , 2010, Nature Medicine.

[7]  H. Broxmeyer,et al.  New approaches for improving engraftment after cord blood transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  R. O’Keefe,et al.  In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. , 2009, Blood.

[9]  H. Broxmeyer,et al.  Experimental basis of cord blood transplantation , 2009, Bone Marrow Transplantation.

[10]  J. Tisdale,et al.  Development of a Human Immunodeficiency Virus Type 1-Based Lentiviral Vector That Allows Efficient Transduction of both Human and Rhesus Blood Cells , 2009, Journal of Virology.

[11]  J. Sampath,et al.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. , 2009, Blood.

[12]  L. Zon,et al.  Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration , 2009, Cell.

[13]  Marie-Laure Dichtel-Danjoy,et al.  SoxF is part of a novel negative-feedback loop in the wingless pathway that controls proliferation in the Drosophila wing disc , 2009, Development.

[14]  H. Lodish,et al.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. , 2008, Blood.

[15]  K. Ottersbach,et al.  Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells , 2007, Proceedings of the National Academy of Sciences.

[16]  K. Pollok,et al.  Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. , 2007, Stem cells and development.

[17]  M. Konopleva,et al.  Phase I trial of parathyroid hormone to facilitate stem cell mobilization. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  L. Zon,et al.  Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis , 2007, Nature.

[19]  D. Scadden,et al.  Therapeutic targeting of a stem cell niche , 2007, Nature Biotechnology.

[20]  S. Armstrong,et al.  FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.

[21]  B. Yeap,et al.  Double unrelated reduced-intensity umbilical cord blood transplantation in adults. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  D. Aronoff,et al.  Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation1 , 2006, The Journal of Immunology.

[23]  R. Moon,et al.  Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation , 2006, Nature Medicine.

[24]  C. Dunbar,et al.  Large Animal Models for Stem and Progenitor Cell Analysis , 2005, Current protocols in immunology.

[25]  J. Wingard,et al.  Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors , 2002, Transfusion.

[26]  N. Ferrara,et al.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism , 2002, Nature.

[27]  J. Campos-Ortega,et al.  Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.

[28]  J. Jones,et al.  Assessment of barriers to bone marrow donation by unrelated African-American potential donors. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  R. Willemze,et al.  Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. , 1995, Blood.

[30]  J. Regan,et al.  Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. , 1994, Molecular pharmacology.

[31]  B. Dörken,et al.  Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. , 1993, Bone marrow transplantation.

[32]  H. Broxmeyer,et al.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.